Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Yu-Chien Lin
(Contributor)
Kuo-Chang Wen
(Creator)
Pi Lin Sung
(Contributor)
Yu Ting Chou
(Creator)
Phui-Ly Liew
(Contributor)
Lin Yu Chen
(Contributor)
Rui-Lan Huang
(Creator)
Hung-Cheng Lai
(Contributor)
Lu-Te Chang
(Contributor)
Taipei Medical University Shuang Ho Hospital
Department of Obstetrics and Gynecology
Department of Pathology
TMU Research Center of Cell Therapy and Regeneration Medicine
TMU Research Center of Cancer Translational Medicine
International Ph.D. Program in Cell Therapy and Regenerative Medicine
International Master/Ph.D. Program in Medicine
Graduate Institute of Clinical Medicine
Dataset
Overview
Research output
(1)
Research output
Research output per year
2020
2020
2020
1
Article
Research output per year
Research output per year
1 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Filter
Article
Search results
2020
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y. C.,
Wen, K. C.
, Sung, P. L., Chou, Y. T.,
Liew, P. L.
, Chen, L. Y., Huang, R. L.,
Lai, H. C.
&
Chang, L. T.
,
Dec 2020
,
In:
Journal of Ovarian Research.
13
,
1
, 143.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
Combination Therapy
100%
Clear Cell Carcinoma
100%
Bevacizumab
100%
Pembrolizumab
100%
Neoplasm
60%
8
Citations (Scopus)